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Salmonellosis is one of the major global health concerns leading to millions of deaths annually. The 
present vaccines not being up to the mark necessitate the need for the development of new generation 
vaccines. Outer membrane proteins (Omps) of several Gram negative bacteria have been investigated 
and found to be immunogenic and protective. The present study explores the potential of a major porin 
protein (OmpC) of Salmonella Typhimurium, as a vaccine candidate. The OmpC 3D structure and its 
potential to bind effectively with antibodies and generate humoral response was investigated using in 
silico docking, and expressed in a heterogeneous Escherichia coli M15 host strain. The rOmpC was 
purified and its immunopotential was evaluated in vitro by western blotting and in vivo in three weeks 
old chicks. The recombinant OmpC produced a significant humoral response and in vaccinated birds 
100% survival rate was observed along with delay in the shedding of organism in droppings. These 
findings indicate that the rOmpC vaccination prevents mortality in chicken and lowers fecal shedding in 
droppings.  
 






Salmonellosis is a major health concern affecting a large 
population globally. Salmonella enterica, the causative 
agent of Salmonellosis results in food borne illnesses and 
gastroenteritis in human beings and other mammals 
(Sharma, 2003). Due to its high physiological adaptability 
and broad host range it is difficult to devise prevention 
and control strategies against Salmonellosis. Although, 
the incidence rate of typhoidal Salmonellosis has been 
significantly controlled by vaccination and drugs, but non-








rate in the last 15 years as indicated by Department of 
Health (2011). The major serovars contributing to the 
prevalence of Salmonellosis worldwide are Salmonella 
Typhimurium and Salmonella Enteritidis (Ekdahl et al., 
2005; Laupland et al., 2010). Globally, non-typhoidal 
Salmonellosis results in over 1.3 billion cases and 3 
million deaths annually (Pui et al., 2011), poultry products 
being the major source. The limitations in curbing the 
zoonotic transmission of such non-typhoidal serovars are 
a major drawback in the field which poses a risk to animal 
as well as human health. Therefore, it is essential to 
develop effective vaccination and strict biosecurity 
measures in such a manner that the transmission of S. 
Typhimurium through poultry is halted to break the circle 
of continuous infections. Hence, in this study recombinant 
antigenic product from S. Typhimurium is studied as a 
poultry vaccine which can strongly inhibit the zoonotic 
transmission. 
Salmonella serovars were used to produce killed 
bacterins (Nicholas and Andrews, 1991) and attenuated 
vaccines by culturing the vaccine strain in iron-deficient 
medium (Woodward et al., 2002). Killed vaccines are 
usually less effective as they only contain surface 
antigens that give an incomplete protective antibody 
response, they fail to elicit cell-mediated immune 
response and they fail to elicit production of secretory 
immunoglobulin (sIgA) response. Attenuated vaccines 
have drawbacks like immune-suppression and fecal 
shedding in vaccinated animals (Barrow and Wallis, 
2000). Moreover, the recent emergence of antibiotic 
resistance and reversal of pathogenicity in Salmonella 
further strengthen the requirement of an effective vaccine 
management of Salmonellosis. Several bacterial 
components like adhesive proteins, polysaccharides, 
lipoproteins and outer membrane proteins have been 
investigated as immunogens (Yap et al., 2001; Lin et al., 
2001; Wolfenden et al., 2010; Bouzoubaa et al., 1987, 
1989) which may be protective. Such factors which 
interface the cell with the environment may be efficiently 
used as immunogens so as to stimulate the development 
of protective immunity. The outer membrane proteins 
(Omp(s)) of Salmonella are considered functional 
candidates as they represent crucial virulence factors 
with a significant role in the pathobiology of gram 
negative bacteria and bacterial adaptation (Hamid and 
Jain, 2008). 
Porins represent the most abundant class of Omp(s) 
that have been elucidated to be protective (Calderon et 
al., 1986; Isibasi et al., 1988) in few serovars of 
Salmonella (Prejit et al., 2013). They have important role 
in the maintenance of bacterial physiology aiding transport 




of small hydrophilic molecules (Nikaido, 1996), having a 
potential role as immunogens in diagnostic assays and 
vaccination (Hamid and Jain, 2008; Aron et al., 1993; 
Secundino et al., 2006; Singh and Sharma, 1999). 
Specific humoral and cellular immune responses are 
mounted against Salmonella Omp(s) (Aron et al., 1993; 
Secundino et al., 2006; Begum et al., 2008; Bhat and 
Jain, 2010; Prejit et al., 2013). Several outer membrane 
Salmonella proteins have been characterized, evaluated 
and found to be immunodominant in poultry (Wyszynska 
et al., 2004; Begum et al., 2008; Meenakshi et al., 1999; 
Nicholas and Andrews, 1991).  
Outer membrane proteins when administered together 
were found to control fecal shedding of organisms in 
vaccinated birds (Meenakshi et al., 1999; Prejit et al., 
2013). These porins of Salmonella contain T cell 
immunodominant antigenic regions and are involved in 
providing protection in typhoid fever and murine 
salmonellosis (Quinonez et al., 2004). OmpC, a major 
porin protein was found to be synthesized and 
incorporated into the outer membrane at both low and 
high osmolarity conditions (Arockiasamy and 
Krishnaswamy, 2000) depicting its role in both free living 
condition and infection. It is a good candidate to display 
heterologous epitopes on the cell surface (Puente et al., 
1995; Arockiasamy et al., 2004a) and the detailed 
structural properties have been clearly elucidated B 
(aalaji et al., 2006; Baalaji et. al., 2006). The 
immunogenic potential was earlier studied and it was 
observed to be imunodominant and thermostable protein 
(Verma et al., 2009; Jailkhani et al., 2007). Hence, OmpC 
is considered as a potential candidate for the 
development of a subunit vaccine against Salmonellosis 
(Prejit et al., 2013). Further, OmpC-OmpF mutant was 
found to possess attenuated virulence (Chatfield et al., 
1991) revealing its role in pathogenesis and was also 
observed to confer long lasting and specific humoral 
response against the pathogen (Secundino et al., 2006). 
As the isolation of Omp(s) is a tedious task, production of 
recombinant proteins has been considered as an 
alternative improved strategy. The present study deals 
with the evaluation of OmpC as a vaccine candidate. 
Initially, 3D structure, epitope mapping and docking 
studies were conducted so as to evaluate the immune-
potential of the protein in silico. The protein was further 
expressed in a heterogenous system, purified and 
analyzed by SDS-PAGE and Western Blotting for in vivo 
evaluation in model organisms. The in vivo studies of 
recombinant protein in chicken, further illustrates its role 
as a vaccine candidate with a need for a more detailed 
study. 
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The culture of S. enterica subsp. enterica serovar Typhimurium 
MTCC 3231 was procured from Institute of Microbial Technology 
(IMTECH, Chandigarh). The Escherichia coli M15 cells were used 





Twenty one days old White Leghorn chicks were procured from 
Instructional Poultry Farm, G.B. Pant University of Agriculture and 
Technology, Pantnagar. All experiment were approved and in 
accordance with the guidelines of Committee for the purpose of 
Control and Supervision of Experiments on Animals (CPCSEA). 
The birds were reared under hygienic condition and provided with 
feed and water ad libitum. 
 
 
Verification of ompC clone 
 
The ompC gene from S. Typhimurium MTCC 3231, was cloned in 
pJET1.2 blunt cloning vector using primers: Forward primer—5’ 
GGATCCATGCGTATCGGCTT 3’, Reverse primer—5’ 
AAGCTTTTAGAACTGGTAAA 3’ (Clone JET
TM
 PCR cloning kit, 
Fermentas, USA) (Jha et al., 2012) and sequenced by Ocimum 
Biosolutions Ltd., Hyderabad. The recombinant plasmid was 
purified by alkali lysis method (Sambrook and Russell, 2001), and 
was verified by double digestion using BamHI and HindIII.  
 
 
Expression of recombinant 38.5 kDa OmpC protein 
 
The 1.0 kb gene for 38.5 kDa OmpC was directionally subcloned in 
pQE30 expression vector (Khanam et al., 2006) with the 6X His 
Tag. The expression construct was transformed in E. coli M15 host 
cells. Recombinant strains were maintained in Ampicillin (50 µg/ml) 
and Kanamycin (25 µg/ml) and induced with 1 mM 
isopropylthiogalactoside (IPTG) after OD600 reached 0.5 to 0.7 
(Sambrook and Russell, 2001). The expression of recombinant 




Purification of recombinant 38.5 kDa protein by Ni-NTA affinity 
chromatography 
 
The cell lysate was loaded onto the column of His-Select Nickel 
Affinity gel (Ni-NTA resin, Sigma, USA), pre-equilibrated with 
equilibration buffer (100 mM NaH2PO4, 10 mM Tris base, 8 M Urea, 
pH 8.0). The column was washed with 25 column volumes of wash 
buffer (pH 7.5), the bound fractions were eluted with 5 ml of elution 
buffer (pH 4.5) and analyzed by 12.5% SDS-PAGE and quantified 
using Lowry’s method (Lowry et al., 1951). 
 
 
In silico analysis of ompC gene sequence 
 
The ompC gene sequence (Acc. No. JF896322) was characterized 
and the putative 3-D structure was determined. Structural analysis 
was conducted using EsyPred3D (Lambert et al., 2002) for 
determination of the 3-D structure. Jmol was used as a visualization 
tool. The Ramachandran plot of the sequence was predicted and 






Rigid body docking prediction of OmpC recombinant protein 
with representative antibodies  
 
The receptor antibody models were extracted from Protein Data 
Bank to study the potential ability of OmpC to strongly bind with the 
antibodies. HexServer (Macindoe et al., 2010) was used for rigid 
body Antigen-Antibody docking using OmpC 3D structure, with 
Range angles of 180° and Step sizes at 7.5. A non-specific 6D 
docking run was conducted using default values for all parameters. 
Since the macromolecules have shape and charge comple-
mentarity, shape plus electrostatic calculations were made. The 
server screens the possible complementarities and clusters the 
solutions with similar orientations for shape plus electrostatic 
correlations (N = 25 or N = 30) to give sharper results. The best 
docking predictions were visualized and the docking energy was 
determined to evaluate the stability of the in silico complexes. 
 
 
Raising hyperimmune sera against total Omp(s) 
 
The Omp(s) of S. Typhimurium were isolated as per the protocol 
described by Choi-Kim et al. (1991). Briefly, 1 L of S. Typhimurium 
culture suspension was sonicated in 10 mM HEPES buffer (pH 7.4). 
The suspension was centrifuged at 1,00,000 xg for 60 min at 4°C 
and washed in 2 ml of 2% (w/v) sodium lauryl sarcosinate. 
Hyperimmune serum was raised in New Zealand White rabbit. The 
animal was subcutaneously injected with 500 µg of Omp(s) 
emulsified in Freund’s complete adjuvant, followed by 250 µg of 
protein as first and second booster at 10 and 21 days, respectively. 
Serum samples were collected from ear vein at seven days post 
final booster. Agglutination reaction was performed on a slide with a 
layer of 1% agarose in normal saline. Three wells were cut using a 
well borer at a distance of 1 cm from each other. 50 µl of total 
Omp(s) was added to one well, 50 µl of serum was added to the 
middle well and 50 µl autoclaved water was added to the last well. 
The slide was kept in a moist chamber for 48 h after which 





Purified recombinant protein was electroblotted on polyvinylidine 
fluoride (PVDF) membrane using semi-dry method at 0.8 A/cm
2
 as 
described by Towbin et al. (1979). The membrane was blocked with 
1% BSA, incubated with Omp antiserum at 37°C for 1 h, washed 
and incubated again with anti-rabbit HRP conjugated antibodies at 
37°C for 1 h. Further, substrate solution (50 mM Tris-HCl pH 7.6, 
0.6 mg/ml 3-3’ Diaminobenzidine, 0.6 µl/ml 30% H2O2) was added 
and the signal was developed and analyzed. 
 
 
Immunization and humoral response in poultry 
 
Thirty (30) white Leghorn birds, 21 days old were divided into two 
equal groups for immunization studies. Group I was subcutaneously 
injected with 100 µg saponin from quillaja bark (Sigma Aldrich) in 
phosphate buffer saline as control Group II was injected with 150 
µg of recombinant purified protein formulated with 100 µg saponin 




 day were followed by a 
booster dose on 28
th
 day and the blood samples were collected 
from wing vein on 7 and 14
th
 day post immunization. The serum 
samples were analyzed for antibody titre using ELISA. The OmpC 
protein was coated (100ng/well) into the wells of ELISA plate and 
kept at 4°C for overnight. After washing, 100 µl of blocking solution 
(2% BSA in PBS) was added and the plate was kept at 37°C for 1 
h. The plates were washed thrice with washing solution (PBS 





was added and the plates were incubated for two hours at 37°C. 
After third washing 100 µl of anti-mouse HRP conjugated antibody 
diluted 1:3000 times was added and the plates were kept in 
incubation for one hour at 37°C. The substrate solution (24.3 ml of 
0.1 M citric acid, 25.7 ml of 0.2 M dibasic sodium phosphate 
solution, 40 mg orthophenyl diamine (OPD), 0.04 ml of hydrogen 
peroxide and 50 ml of triple glass distilled water) was prepared 
during the time of incubation. The plates were washed thrice with 
washing solution. Then, 100 µl of OPD substrate was added and 
the plates were in incubated at room temperature in dark for 30 
min. Then 100 µl of 1.5 N NaOH was added to each well. The OD 
was observed at 492 nm. Two weeks post immunization; birds were 
challenged with 100 µl culture containing 10
9
 cfu of S. Typhimurium 
3231 culture strain intraperitoneally. The challenge strain 
administered intraperitoneally allows the development of clear 
symptoms, lethargic behavior and mortality. The birds were 
monitored for clinical signs, mortality and shedding of challenge 
strain using cloacal swab cultures for 10 days. The cloacal swabs 




 day post challenge, enriched in 
tetrathionate (TT) broth and verified on Brilliant Green Agar to 





The statistical analysis for comparison between mortality and 
shedding rates was performed using paired and unpaired Student’s 
t-test and the mean titre was calculated by deriving the mean of 
logarithmic value of reciprocal of titre with standard error. The 
results of challenge studies were analyzed using Chi square test 
with Yate’s correction. 
 
 
RESULTS AND DISCUSSION 
 
Heterologous expression of ompC gene 
 
The expression cassette was verified by restriction 
analysis and transformed in heterologous E. coli M15 
cells. The recombinants were screened for the expres-
sion of recombinant OmpC by analyzing mini prep 
cultures on SDS-PAGE.  
The recombinant protein (rOmpC) was found to 
express effectively under the regulated control of IPTG as 
inducer. The induced protein appeared to be of 38.5 kDa 
and the expression was found to be significantly high 
indicating a large proportion of the protein synthesis 
machinery being directed for the expression of 
recombinant protein.  
 
 
Purification and quantification of rOmpC 
 
The rOmpC was purified using Ni-NTA affinity chroma-
tography and recombinant protein eluted at pH 4.5 was 
found to be almost pure in SDS-PAGE analysis (Figure 
1b). The protein yield of 30 g/L (3 g/100 ml) of bacterial 
culture was obtained which was estimated by Lowry’s 
method and further concentrated by dialysis. The high 
expression level of the rOmpC would aid in generating 
immunodiagnostics and vaccines. 




3D structure predictions of rOmpC protein and rigid 
body molecular docking with representative 
antibodies 
 
The protein was predicted to have 15 antiparallal β- 
sheets forming a β- barrel characteristic of Gram negative 
bacterial porins. Five alpha helical regions were observed 
distributed in the protein sequence. Out of them three 
were found to be located on the extracellular surface of 
the membrane. One was localized in the hydrophillic loop 
region directed intracellularly. The fifth helix was found to 
be located within the pore of the protein. It probably 
contributes in providing a hydrophilic surface within the 
pore, for the effective transport of hydrophilic molecules. 
The β- barrel region of the protein constitutes the 
transmembrane region being hydrophobic in nature. In 
silico studies revealed pore size of ~1.25 nm (Figure 2a, 
b) which was slightly more than 1.1 nm as predicted by 
Baalaji et al. (2006), for S. Typhi (Morris et al., 1992). 
The Ramachandran plot showed the phi-psi torsion 
angles for all residues in the structure (except those at 
the chain termini) (Figure 2c). The darkest areas "core" 
regions (red) represented the most favourable 
combinations of phi-psi values (Morris et al., 1992). It was 
observed that 86.2% of the residues were present in the 
favoured regions except Tyrosine -90 and aspartic acid -
273 in the fourth quadrant, although no residues were 
found in the disallowed regions of the plot 
(Supplementary 1) indicating stable and favourable 
protein structure. Further, it was observed that the 
regions in the sequence having high surface probability, 
have a high antigenic index and the transmembrane 
regions were found to be highly conserved in Salmonella 
and E. coli (Puente et al., 1995). 
 
 
Interaction of OmpC antigen with antibody receptors 
of surface proteins 
 
To study the antigenic potential of the protein in silico, 
eight antibody models against surface proteins were 
selected and extracted from PDB. The Docking was done 
using HexServer (Macindoe et al., 2010) (Table 1) and 
binding energies were obtained. These binding energies 
correlated with high stability and shape complemen-
tarities between the receptor and ligand 3D structures 
(Figure 3a-h). The negative values predicted the stability 
and strength of rigid body docking predictions. Since, the 
binding energy is indicative of interaction energy, Vander 
Waals forces and hydrophobic interactions, the 
conclusion was made that the antigen may be a probable 
ligand for such antibodies within the host system. The in 
silico energy correlations emphasize the predictive 
immunogenic property of the recombinant antigen and its 
probable interaction with B-cell receptor molecules 
generated during adaptive immune responses. 






Figure 1. (a) Western blot, L1- purified OmpC protein, L2- prestained protein mol.wt. marker (Fermentas). (b) 
Purification of recombinant 38.5kDa OmpC protein by Ni-NTA affinity chromatography. L1- unstained protein mol.wt. 
marker (GeNei
TM






Figure 2. (a-c) The 3-Dimensional structure of OmpC porin protein predicted using EsyPred3d online resource and Jmol as visualization 
tool, showing major transmembrane β-sheet regions and exposed α-helical structures- front view and top view. (c) Ramachandran plot for 















Table 1. List of representative Receptors and their relevant interaction energies with the OmpC protein 3D structure.  
 




E total (kcal/mol) 
P01867 
(IGG2B) 
Ig gamma-2B chain C region. Igh-3 2.0 -818.31 
7FAB Crystal Structure of Human Immunoglobulin Fragment FAB. IGG1 2.0 -1296.89 
1MAM Crystal Structure of Monoclonal FAB specific for Brucella A cell wall. Igh-3 2.45 -763.87 
1IGA 
Model of IGA1 determined by Solution Scattering curve fitting and Homology 
modeling. IGH1 
 -8514.05 
1IGY Crystallographic structure of an intact IgG1 monoclonal antibody 3.2 -1753.32 
1KCU Crystal structure of Antibody PC287. Ig kappa chain C region 2.2 -893.53 
1KCV Crystal structure of antibody PV282. 1.8 -1167.93 










Study of immunopotential of OmpC protein 
 
The immunogenic potential of rOmpC was evaluated by 
western blotting and a sharp band was observed with anti 
Omp antisera indicating a strong humoral response of 
38.5 kDa rOmpC in animal model as compared to total 
outer membrane proteins used for immunization (Figure 
1a). In correspondence with the earlier in silico studies of 
ompC gene was done using Immune Epitope Database. 
The presence of many epitopes was revealed in the 
sequence including 13 B-cell epitopes, out of which eight 
were predicted to be strongly immunogenic, 14 MHC I 
and several MHC II epitopes (Jha et al., 2012). Further, 
eight major variable regions were found by multiple 
sequence alignment with the related sequences having 
high surface probability and B-cell recognition potential,  
indicating the high immunogenic potential of the putative 
protein (Jha et al., 2012). These in silico studies 
conducted earlier by us and western blot directed the 
animal trials for OmpC protein.  
 
 
Assessment of immunogenic potential in poultry 
 
A strong humoral immune response was elicited in 
immunized group. The mean of logarithm of reciprocal of
 
 






Figure 4. Comparative evaluation of recombinat OmpC antibody titres in immunized White Leghorn by 




Table 2. Evaluation of the percentage of birds shedding the 
organism in immunized group as compared to control group. 
 
Group 








Unimmunized control 0% 58% 83% 




titre was estimated to be 4.40 ± 0.077 for 7
th
 (1:29400) 
and 4.46 ± 0.06 for 14
th
 day (1:32000) samples. The 
mean OD at a dilution of 1:25600 was calculated and the 
results were compared with that of control group (Figure 
4). No statistically significant association was found in the 
humoral responses in control and vaccinated groups (p 
value = 0.064) revealing a strong significant antibody 
response generated in the vaccinated group as 





To assess the protective response generated against 
bacterial challenge, the immunized and control group was 
challenged 2 weeks post immunization. Birds in the 
immunized group did not show any apparent symptoms 
of Salmonellosis although the control group showed 
lethargic movements and decreased response to stimuli. 
In the control group, out of 15, 4 birds died at 0, 1, 3 and 
4
th
 day post challenge, although no mortality was 
observed in immunized group (Table 2). Cloacal swabs 
from all surviving birds were evaluated to estimate 
shedding. The S. Typhimurium virulent strain was 
identified in swabs samples using Salmonella specific 
PCR. The shedding percentage in control group was 




 day, respectively, 
while in the case of immunized group it was 20 and 33% 
with no mortality. The fecal shedding of virulent strain 
was observed to be lower but not completely controlled in 
immunized birds than in unimmunized control. The 
association of immunization with rate of survival and with 
shedding was estimated by applying Chi-square test with 
Yate’s correction. It was found that there was no 
significant association between immunization and the 
rate of survival of birds (p = 0.1071) (Supplementary 3). 
Similarly, no significant association was observed 
between immunization and shedding of bacteria (p = 
0.3279) (Supplementary 4). Although, recombinant 
OmpC induced strong humoral response but fecal 
shedding of bacteria was slightly lowered and not 
effectively controlled. Persistence of infection was 
observed in some vaccinated birds. The humoral immune 
response developed by rOmpC immunization was found 
to be effective in controlling shedding in ~60% birds 
during challenge studies. 
Porin proteins form β-barrels with long hydrophilic loops 
and short β-hairpin turns connecting strands on the 
external and periplasmic surfaces of the bilayer (Cowan 
and Rosenbusch, 1994). Their primary structure varies 
significantly among Gram-negative bacteria (Gerbl-Rieger 
et al., 1991), but amphiphilic β strands in the barrel are 
structurally conserved (Jeanteur et al., 1994). It was 
found that OmpC of S. Typhimurium folds in a similar way 
as OmpF of E. coli and OmpC of S. Typhi (Arockiasamy 








expression of OmpC during infection (Puente et al., 1989; 
Verma et al., 2009) and its capacity to display 
heterologous epitopes on the cell surface (Puente et al., 
1995) make it an important candidate antigen with 
potential applications in immunology and vaccine design. 
Studies using Salmonella porin specific monoclonal 
antibodies (Muthukkaruppan et al., 1992) showed that S. 
Typhi OmpC is the major surface antigen with unique 
exposed epitopes. The immunogenicity of outer membrane 
proteins was evaluated in birds and was found to be 
significantly high (Meenakshi et al., 1999), indicating that 
systemic immunity may play a role in protection. Hamid 
and Jain immunized different groups of mice with 
selected proteins. Their ELISA results indicated that the 
protein elicits a significant humoral response and different 
levels of protection. Maximum survival was seen in the 
animals immunized with 49 kDa protein (100%), followed 
by 37 kDa (66.7%), 33 kDa (50%) and 15kDa (33.3%) 
(Hamid and Jain, 2008). Verma et al. (2009) evaluated 
the immunogenicity of the recombinant porins, in Swiss 
albino mice with three different adjuvants. In contrast to 
OmpF, the high titer (p < 0.05) of recombinant OmpC-
specific IgG antibody was observed in mice immunized 
with aluminium hydroxide gel followed by Freund’s 
adjuvant and montanide. The marked IgG responses in 
mice immunized with OmpC and OmpF supported the 
immunogenic nature of these recombinant porins and 
suggests that these may be used as good immunogens 
for vaccine studies (Verma et al., 2009). Another 
immunodominant surface protein of 37.81 kDa was 
immunologically characterized in vivo in chicks which 
induced homologous or heterologous protective efficacy 
against the infection of Salmonella serovars (Begum et 
al., 2008). 
In the present study, although a strong humoral 
response was generated but the shedding of bacteria 
form fecal route was not completely eradicated, although 
significant reduction in mortality was observed. The 
generation of cell mediated response against Salmonella 
may be targeted in future studies by using adjuvants 
having depot formation property. Liposomes and ISCOMs 
have been reported to generate CTL induction and act as 
immunomodulators. These adjuvants may be used for 
providing the cell mediated immune response for 






Such results highlight the fact that the protein being a 
potent immunogen generates partially protective 
antibodies. These partially protective antibodies 
generated contribute in suppressing mortality along with 
slight reduction in fecal shedding of the pathogen in 
challenged birds. Although the antibodies may not 
participate in lowering zoonotic transmission, it may be 
hypothesized that they may play significant role in curbing 




mortality from virulent pathogen. Hence, it may be 
concluded that the protein OmpC, being immunogenic is 
partially protective in nature. The improvement in survival 
rate, suppression of physiological symptoms and 
reduction in fecal shedding signify the fact that the 
antibodies generated in the host system are partially 
protective. Therefore, OmpC protein may be considered 
as strongly immunogenic and partially protective. Further, 
the protective efficacy of the recombinant protein may be 
improved by focusing on specific epitopes and modula-
ting the regions which improve protectivity through in 
silico experimentation. Furthermore, improvements such 
as new and advanced vaccine delivery systems like 
nano- drug delivery particles, ISCOMs, Liposomes etc 
which work as immunomodulators may be incorporated. 
These adjuvants may also be useful for providing cell 
mediated immune response which would further aid in 
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